[1]
|
Bron, A.J., De Paiva, C.S., Chauhan, S.K., et al. (2017) TFOS DEWS II Pathophysiology Report. The Ocular Surface, 15, 438-510. https://doi.org/10.1016/j.jtos.2017.05.011
|
[2]
|
中华医学会眼科学分会角膜病学组. 干眼临床诊疗专家共识(2013年) [J]. 中华眼科杂志, 2013, 49(1): 73-75.
|
[3]
|
Pucker, A.D., Ng, S.M. and Nichols, J.J. (2016) Over the Counter (OTC) Artificial Tear Drops for Dry Eye Syndrome. Cochrane Database of Systematic Reviews, 2, Cd009729. https://doi.org/10.1002/14651858.CD009729.pub2
|
[4]
|
帖彪, 乔宝笛. 人工泪液对LASIK术后干眼症的疗效观察[J]. 医药论坛杂志, 2009, 30(11): 19-21.
|
[5]
|
黄彩虹, 刘祖国, 李炜, 等. 质量分数0.3%玻璃酸钠滴眼液治疗轻中度干眼的多中心临床试验[J]. 中华实验眼科杂志, 2018, 36(12): 936-941.
|
[6]
|
Aguilar, A., Berra, M., Trédicce, J., et al. (2018) Efficacy of Polyethylene Glycol-Propylene Glycol-Based Lubricant Eye Drops in Reducing Squamous Metaplasia in Patients with Dry Eye Disease. Clinical Ophthalmology, 12, 1237-1243.
https://doi.org/10.2147/OPTH.S164888
|
[7]
|
冷远梅, 蔡东梅. 聚乙二醇眼液治疗白内障术后干眼症患者的疗效[J]. 国际眼科杂志, 2013(11): 2351-2352.
|
[8]
|
杨永利, 杨玉洁, 李鹏, 等. 卡波姆眼用凝胶联合rhEGF治疗糖尿病患者白内障术后干眼症[J]. 国际眼科杂志, 2014(9): 1656-1658.
|
[9]
|
邓志宏, 赵少贞, 张未娟, 等. 立宝舒卡波姆眼用凝胶治疗干眼的临床观察[J]. 国际眼科杂志, 2009, 9(8): 1540-1542.
|
[10]
|
Tauber, J., Davitt, W.F., Bokosky, J.E., et al. (2004) Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafosol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye. Cornea, 23, 784-792.
https://doi.org/10.1097/01.ico.0000133993.14768.a9
|
[11]
|
Yerxa, B.R., Mundasad, M., Sylvester, R.N., et al. (2002) Ocular Safety of INS365 Ophthalmic Solution, a P2Y2 Agonist, in Patients with Mild to Moderate Dry Eye Disease. Advances in Experimental Medicine and Biology, 506, 1251-1257. https://doi.org/10.1007/978-1-4615-0717-8_180
|
[12]
|
Tanioka, H., Kuriki, Y., Sakamoto, A., et al. (2014) Expression of the P2Y₂ Receptor on the Rat Ocular Surface during a 1-Year Rearing Period. Japanese Journal of Ophthalmology, 58, 515-521.
https://doi.org/10.1007/s10384-014-0342-4
|
[13]
|
Kang, D.H., Lee, Y.W., Hwang, K.Y., et al. (2019) Changes of Tear Film Lipid Layer Thickness by 3% Diquafosol Ophthalmic Solutions in Patients with Dry Eye Syndrome. International Journal of Ophthalmology, 12, 1555-1560.
https://doi.org/10.18240/ijo.2019.10.06
|
[14]
|
Koh, S., Maeda, N., Ikeda, C., et al. (2013) Effect of Instillation of Eyedrops for Dry Eye on Optical Quality. Investigative Ophthalmology & Visual Science, 54, 4927-4933. https://doi.org/10.1167/iovs.13-12409
|
[15]
|
Thulasi, P. and Djalilian, A.R. (2017) Update in Current Diagnostics and Therapeutics of Dry Eye Disease. Ophthalmology, 124, S27-S33. https://doi.org/10.1016/j.ophtha.2017.07.022
|
[16]
|
Hong, S., Kim, T., Chung, S.H., et al. (2007) Recurrence after Topical Nonpreserved Methylprednisolone Therapy for Keratoconjunctivitis Sicca in Sjögren’s Syndrome. Journal of Ocular Pharmacology and Therapeutics, 23, 78-82.
https://doi.org/10.1089/jop.2006.0091
|
[17]
|
Wan, K.H., Chen, L.J. and Young, A.L. (2015) Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis. The Ocular Surface, 13, 213-225.
https://doi.org/10.1016/j.jtos.2014.12.006
|
[18]
|
Sall, K., Stevenson, O.D., Mundorf, T.K., et al. (2000) Two Multicenter, Randomized Studies of the Efficacy and Safety of Cyclosporine Ophthalmic Emulsion in Moderate to Severe Dry Eye Disease. CsA Phase 3 Study Group. Ophthalmology, 107, 631-639. https://doi.org/10.1016/S0161-6420(99)00176-1
|
[19]
|
李美霞, 郑金华. 干眼治疗方法的研究进展[J]. 中国社区医师, 2020, 36(7): 4-5.
|
[20]
|
Singer, D.D., Kennedy, J. and Wittpenn, J.R. (2015) Topical NSAIDs Effect on Corneal Sensitivity. Cornea, 34, 541-543.
https://doi.org/10.1097/ICO.0000000000000309
|
[21]
|
Lollett, I.V. and Galor, A. (2018) Dry Eye Syndrome: Developments and Lifitegrast in Perspective. Clinical Ophthalmology, 12, 125-139. https://doi.org/10.2147/OPTH.S126668
|
[22]
|
Donnenfeld, E.D., Karpecki, P.M., Majmudar, P.A., et al. (2016) Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients with Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study. Cornea, 35, 741-748.
https://doi.org/10.1097/ICO.0000000000000803
|
[23]
|
Drew, V.J., Tseng, C.L., Seghatchian, J., et al. (2018) Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. Frontiers in Medicine (Lausanne), 5, Article No. 33. https://doi.org/10.3389/fmed.2018.00033
|
[24]
|
Celebi, A.R., Ulusoy, C. and Mirza, G.E. (2014) The Efficacy of Autologous Serum Eye Drops for Severe Dry Eye Syndrome: A Randomized Double-Blind Crossover Study. Graefe’s Archive for Clinical and Experimental Ophthalmology, 252, 619-626. https://doi.org/10.1007/s00417-014-2599-1
|
[25]
|
Sheppard, J.D., Singh, R., Mcclellan, A.J., et al. (2013) Long-Term Supplementation with n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial. Cornea, 32, 1297-1304. https://doi.org/10.1097/ICO.0b013e318299549c
|
[26]
|
林通, 龚岚. 性激素与干眼的相关性研究进展[J]. 中华眼科杂志, 2014, 50(1): 65-68.
|
[27]
|
邵毅, 吴康瑞, 叶蕾. 干眼的发病机制及治疗研究进展[J]. 眼科新进展, 2020, 40(4): 301-306.
|
[28]
|
Dogru, M., Kojima, T., Simsek, C., et al. (2018) Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease. Investigative Ophthalmology & Visual Science, 59, DES163-DES168.
https://doi.org/10.1167/iovs.17-23402
|
[29]
|
卞茹, 鲁建华, 张文芳. 绝经后干眼症妇女泪液与血清雌激素质量浓度的分析[J]. 眼科研究, 2009, 27(11): 1031-1034.
|
[30]
|
(2007) The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). The Ocular Surface, 5, 75-92.
https://doi.org/10.1016/S1542-0124(12)70081-2
|
[31]
|
梁庆丰. 干眼患者诊治的精细化管理[J]. 眼科, 2016, 25(3): 145-147.
|
[32]
|
唐颖, 田甜, 葛红岩. 干眼症发病机制与发病因素的研究进展[J]. 医学综述, 2019, 25(11): 2196-2201.
|